An 87% cure rate of HC by tumor resection alone in children with posterior fossa astrocytoma warrants no change in treatment strategy. However, the low cure rate of HC by tumor resection alone in patients with medulloblastoma and ependymoma raises the issue of whether these patients would benefit from preresection ETV.
No takes yet. Share an insight, caveat, or question.
Due‐Tønnessen et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: